1-6 of 6
X. Wei
Close
Sort by
Journal Articles

Assessing Epidemiological Differences in Myelofibrosis: A Comparative Study of a Single-Center Cohort and the SEER National Database

John Yan, John X Wei, Amit Verma, Nishi Shah, Swati Goel
Journal: Blood
Blood (2023) 142 (Supplement 1): 7426.
https://doi.org/10.1182/blood-2023-184932
Published: 2023
Journal Articles

A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses

John X Wei, Nina Samuel, Richard Elkind, Carlo Palesi, Aditi Shastri, R. Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Kira Gritsman, Amit Verma, Mendel Goldfinger, Dennis Cooper, Nishi Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12890–12891.
https://doi.org/10.1182/blood-2022-166689
Published: 2022
Journal Articles

Factors Associated with Early Mortality in Patients with Multiple Myeloma: A SEER Analysis

John X Wei, Alex Sisto, Aditi Shastri, R. Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Urvi A Shah, Murali Janakiram, Kira Gritsman, Amit Verma, Mendel Goldfinger, Dennis Cooper, Nishi Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 11014–11015.
https://doi.org/10.1182/blood-2022-168978
Published: 2022
Journal Articles

BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma

Clinical Trials & Observations
Cristina Correia, Paula A. Schneider, Haiming Dai, Ahmet Dogan, Matthew J. Maurer, Amy K. Church, Anne J. Novak, Andrew L. Feldman, Xiaosheng Wu, Husheng Ding, X. Wei Meng, James R. Cerhan, Susan L. Slager, William R. Macon, Thomas M. Habermann, Judith E. Karp, Steven D. Gore, Neil E. Kay, Diane F. Jelinek, Thomas E. Witzig, Grzegorz S. Nowakowski, Scott H. Kaufmann
Journal: Blood
Blood (2015) 125 (4): 658–667.
https://doi.org/10.1182/blood-2014-04-571786
Published: 2015
Includes: Supplemental data
Journal Articles

Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation

Husheng Ding, Jennifer Hackbarth, Paula A. Schneider, Kevin L. Peterson, X. Wei Meng, Haiming Dai, Thomas E. Witzig, Scott H. Kaufmann
Journal: Blood
Blood (2011) 118 (18): 4872–4881.
https://doi.org/10.1182/blood-2011-02-334870
Published: 2011
Includes: Supplemental data
Journal Articles

A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.

Rebecca B. Klisovic, W. Blum, X. Wei, S. Liu, C. Kefauver, L. Huynh, J. A. Zwiebel, J. C. Byrd, M. R. Grever, G. Marcucci
Journal: Blood
Blood (2005) 106 (11): 2790.
https://doi.org/10.1182/blood.V106.11.2790.2790
Published: 2005